Skip to main content

Ubrogepant News

Ubrogepant During Prodromal Phase of Migraine Eases Symptoms

TUESDAY, May 13, 2025 – Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature Medicine. Peter J. Goadsby,...

Ubrogepant Administered During Prodrome Beneficial for Migraine

WEDNESDAY, Aug. 28, 2024 – For adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes,...

FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine

DUBLIN, Dec. 23, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy (ubrogepant) for...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine, Headache

Related drug support groups

Ubrelvy

Ubrogepant patient information at Drugs.com